feed,title,long_url,short_url
🔐MarketWatch,MannKind initiated with outperform rating and 12-month price target of $10 at Wedbush Securities,http://www.marketwatch.com/tools/quotes/quotes.asp?symb=MNKD&siteid=rss,https://da.gd/L1GiI
🔐MarketWatch,Ventyx Biosciences price target reduced by $1 to $56 at Oppenheimer,http://www.marketwatch.com/tools/quotes/quotes.asp?symb=VTYX&siteid=rss,https://da.gd/CLoOj
